CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 600 enrolled
Drug / intervention
CDI Ptsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02223715
NCT02223715N/ACompleted

A Prospective Study to Characterize the Management and Outcome of Clostridium Difficile Infection (CDI) in Asian Pacific Countries

Otsuka Pharmaceutical Co., Ltd.·observational·Posted Aug 22, 2014·Updated Oct 17, 2016

In Brief

An observational study evaluating CDI Pts for Clostridium Difficile Infection. Completed, enrolled 600 participants across 1 site.

Detailed Summary

The aim of this study is to conduct an Asia-Pacific, multi-center, prospective observational study to characterize patients with CDI as well as to understand treatment and management of the disease.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesJapan
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedAug 22, 2014
Enrollment StartMar 1, 2014
Primary CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 11.9 years ago

Interventions

CDI Ptsother